BDUK Therapeutics develops a groundbreaking liver cancer therapy, utilizing pre-existing drugs combined into a novel and highly potent therapeutic product for an orphan drug disease with optimal G2M strategy. The current Liver cancer market size is $11 Bn, with no effective therapy (20% 5yr surviva... Read more
This company has no teams yet
This company has no offices yet